Co-Diagnostics, Inc. Common Stock (CODX) - Total Liabilities

Latest as of March 2026: $5.46 Million USD

Based on the latest financial reports, Co-Diagnostics, Inc. Common Stock (CODX) has total liabilities worth $5.46 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore CODX net asset momentum to track the company's year-over-year net asset growth rate.

Co-Diagnostics, Inc. Common Stock - Total Liabilities Trend (2014–2025)

This chart illustrates how Co-Diagnostics, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of Co-Diagnostics, Inc. Common Stock to measure how efficiently the company converts operating cash flow to free cash.

Co-Diagnostics, Inc. Common Stock Competitors by Total Liabilities

The table below lists competitors of Co-Diagnostics, Inc. Common Stock ranked by their total liabilities.

Company	Country	Total Liabilities
European Opportunities Trust plc LSE:EOT	UK	GBX66.66 Million
Babylon Pump & Power Ltd AU:BPP	Australia	AU$40.25 Million
Krakatoa Resources Ltd AU:KTA	Australia	AU$356.39K
Gibb River Diamonds Ltd AU:GIB	Australia	AU$196.15K
Vanadium Resources Ltd AU:VR8	Australia	AU$536.13K
Llama Group S.A. PA:ALLAM	France	€18.95 Million
SMX (Security Matters) Public Limited Company Class A Ordinary Shares NASDAQ:SMX	USA	$22.11 Million
Anglo Asian Mining Plc LSE:AAZ	UK	GBX84.38 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Co-Diagnostics, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Co-Diagnostics, Inc. Common Stock (CODX) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.28	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.34	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.25	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Co-Diagnostics, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Co-Diagnostics, Inc. Common Stock (2014–2025)

The table below shows the annual total liabilities of Co-Diagnostics, Inc. Common Stock from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	$4.11 Million	-57.54%
2024-12-31	$9.69 Million	+4.09%
2023-12-31	$9.31 Million	+8.65%
2022-12-31	$8.57 Million	-66.48%
2021-12-31	$25.56 Million	+462.89%
2020-12-31	$4.54 Million	+849.80%
2019-12-31	$478.07K	-81.70%
2018-12-31	$2.61 Million	+221.75%
2017-12-31	$811.80K	-81.08%
2016-12-31	$4.29 Million	+182.58%
2015-12-31	$1.52 Million	+1152.55%
2014-12-31	$121.22K	--

About Co-Diagnostics, Inc. Common Stock

NASDAQ:CODX USA Medical Devices

Market Cap

$5.31 Million

Market Cap Rank

#28421 Global

#5754 in USA

Share Price

$1.44

Change (1 day)

-7.69%

52-Week Range

$0.17 - $11.19

All Time High

$30.80